Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v4-EN
Language English English
Date Updated 2019-07-12 2019-07-11
Drug Identification Number 02329778 02329778
Brand name DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC
Common or Proper name Sodium Iodide 131 Sodium Iodide 131
Company Name JUBILANT DRAXIMAGE INC JUBILANT DRAXIMAGE INC
Ingredients SODIUM IODIDE 131 I SODIUM IODIDE 131 I
Strength(s) 7400MBq 7400MBq
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL ORAL
Packaging size 1 Vial 1 Vial
ATC code V10XA V10XA
ATC description
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2019-07-06 2019-07-06
Actual start date
Estimated end date 2019-07-11 2019-07-11
Actual end date 2019-07-11 2019-07-11
Shortage status Resolved Actual shortage
Company comments
Health Canada comments